drug manufacturers
12/10/2017 / By Michelle Simmons
Diabetes drug manufacturers unable to prove any real benefit to patients
Manufacturers of diabetes drugs could not prove any real additional benefit of sitagliptin to individuals with diabetes, according to a report by the Institute for Quality and Efficiency in Health Care (IQWiG). The IQWiG reevaluated the effects of the diabetes drug known as sitagliptin compared to the appropriate comparator therapies for diabetic people. Sitagliptin, which […]
« Return Home
1 of 1

Popular Posts

Medicine.News is a fact-based public education website published by Medicine News Features, LLC.

All content copyright © 2018 by Medicine News Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.